Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril in Diastolic Heart Failure
NCT01411735Phase 3Completed
- Sponsor
- Wake Forest University
- Start
- Jul 2003
- Primary completion
- Jun 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of enalapril in heart failure with preserved ejection fraction (HFpEF), sponsored by Wake Forest University. Started Jul 2003; status: completed.
02
Drugs
enalapril
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01411735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01411735.